Meanwhile, therapeutic potential and toxicity of RIP‐12 or melatonin in regulating RBM10/RORB axis deserve studies by using patient‐derived tumor xenografts or immune‐competent mice models. The gene discussed is RBM10; the disease is neoplasm.